These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 36541400)

  • 21. Vav-family proteins in T-cell signalling.
    Tybulewicz VL
    Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vav1: a hematopoietic signal transduction molecule involved in human malignancies.
    Katzav S
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1245-8. PubMed ID: 19100858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vav1 mutations: What makes them oncogenic?
    Farago M; Yarnitzky T; Shalom B; Katzav S
    Cell Signal; 2020 Jan; 65():109438. PubMed ID: 31654719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulatory effect of Vav1 on T cells and its relation to clinical diseases].
    Zhang Y; Chen W
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):75-81. PubMed ID: 30146815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VAV1: a new target in pancreatic cancer?
    Denicola G; Tuveson DA
    Cancer Biol Ther; 2005 May; 4(5):509-11. PubMed ID: 15970675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
    Morrish E; Wartewig T; Kratzert A; Rosenbaum M; Steiger K; Ruland J
    Eur J Immunol; 2023 Mar; 53(3):e2250147. PubMed ID: 36541400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.
    Katzav S
    Cancer Lett; 2007 Oct; 255(2):241-54. PubMed ID: 17590270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vav1: a key signal transducer downstream of the TCR.
    Tybulewicz VL; Ardouin L; Prisco A; Reynolds LF
    Immunol Rev; 2003 Apr; 192():42-52. PubMed ID: 12670394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases.
    Neurath MF; Berg LJ
    Trends Immunol; 2024 Aug; 45(8):580-596. PubMed ID: 39060140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models.
    Shalom B; Salaymeh Y; Risling M; Katzav S
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
    Katzav S
    Oncotarget; 2015 Oct; 6(30):28731-42. PubMed ID: 26353933
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.